On 10 October 2016, the European Medicines Agency’s (“EMA”) Management Board adopted a reflection paper on the development of a new European Union medicines web portal. The reflection paper sets out a vision for this new portal and its expected benefits. It also details the means to achieve this vision. Background The new portal, taking
On 19 May 2016 the European Medicines Agency (“EMA”) published a draft Reflection paper on non-spontaneous adverse event reports (peer-reviewed literature, internet and social media) (“the Draft Reflection Paper”) for veterinary products.
On 17 December 2015, the European Medicines Agency (“EMA”) published a Reflection Paper on the chemical structure and properties criteria to be considered for evaluation of new active substance (“NAS”) status of chemical substances.